Prof. Dr. Daniel Alejandro Maza, a distinguished Spanish radio-oncologist with an illustrious 36-year career, is renowned for his expertise in IMRT, Brachytherapy, and medical physics. Graduating from the University of Buenos Aires in 1984, he later specialized at the University of Argentina and pursued additional education in radiation oncology at the Institut Curie Paris in 2018. Dr. Maza's professional journey includes significant roles as a radio-oncology specialist and professor at prestigious institutions such as Massachusetts Hospital, Harvard Medical School, and Indiana University in the USA. His wealth of experience is underscored by memberships in esteemed organizations, including the Particle Therapy Co-Operative Group (PTCOG), The European Society for Therapeutic Radiology and Oncology (ESTRO), the French Society for Physical Medicine (SFPM), and the Phelan-McDermid Syndrome Foundation (PMSF). Dr. Maza's extensive contributions to the field are reflected in his numerous authored books and articles, solidifying his status as a respected figure in oncology.
Prof. Dr. Daniel Alejandro Maza is a leading oncology expert in Spain, with profound mastery in advanced cancer treatments such as IMRT (Intensity-Modulated Radiation Therapy), Brachytherapy, and medical physics. His expertise spans a wide range of complex cancers, including lip cancer, colon cancer, bladder cancer, prostate cancer, thyroid cancer, breast cancer, and many more. Known for developing personalized treatment protocols, Dr. Maza applies the latest techniques to ensure precision and safety in every case. At Quironsalud Proton Therapy Center in Madrid, he leads advanced radiotherapy programs designed for both localized and metastatic cancers. His contributions to the medical field are not only clinical but also academic, often invited to international oncology conferences and symposiums. His rich career and dedication make him one of the best and most sought-after cancer specialists in the world, trusted by patients for difficult and rare cancer conditions. With multilingual abilities and patient-centered care, Dr. Maza continues to shape the future of oncology.

